Open AccessCA19-9 as a Predictor of Worse Clinical Outcome in Medullary Thyroid Carcinoma
Author(s) -
Renata Carvalho Alencar,
Daniel Barretto Kendler,
Fernanda Accioly de Andrade,
C Nava,
Daniel Bulzico,
Cencita Cordeiro de Noronha Pessoa,
Rossana Corbo,
Fernanda Vaisman
Publication year - 2019
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000497201
Subject(s) - medicine , carcinoembryonic antigen , ca19 9 , calcitonin , thyroid carcinoma , tumor marker , medullary thyroid cancer , gastroenterology , medullary carcinoma , thyroid , oncology , cancer , pancreatic cancer
Medullary thyroid carcinoma (MTC) is a rare disease, and its classic tumor marker is calcitonin. However, recently, very aggressive cases have been reported to also secrete carbohydrate antigen 19-9 (CA19-9), and its role as a marker of worse prognosis has been questioned. The aim of this study was to analyze the relationship between CA19-9 serum levels and MTC outcomes.